TYPE OF DEAL: Fundraising (PE Fund )
LOCATION OF THE COMPANY: United Kingdom (Europe)
VOLUME: USD 150 Million
DESCRIPTION OF THE COMPANY:
The company focuses on Medical marijuana, cannabis-derived drugs, and CBD. The company has industry veterans who have extensive investing experience of more than 100 years in Cannabis as well as Capital Markets. It has been active in the cannabis sector for the last 4 years and has reviewed over 500 cannabis deals. The company has done 10 financings into 6 companies and deployed over $210m into cannabis. Out of these, they have 2 successful exits and have 2.1X realized MM and 5.2X unrealized MM.
WHAT IS IT FOR THE INVESTORS:
* The company expects an IRR of around 33% and an exit value multiple of 2.3 times.
* The fund has a 3-year investment period, 4-year fund return, plus two 1-year extensions at GP discretion.
* Investors have co-investment rights which are available to any LPs over $2.5m